Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details Narrative)

v3.24.1
Stockholders’ Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended 12 Months Ended
May 31, 2022
Apr. 30, 2022
Mar. 31, 2022
Feb. 28, 2022
Jan. 31, 2022
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Oct. 30, 2023
Jun. 30, 2023
Nov. 30, 2022
Aug. 31, 2022
Subsidiary, Sale of Stock [Line Items]                        
Common stock shares, outstanding             781,503 750,815        
Preferred stock, shares issued             950,000 0        
Preferred stock, par value             $ 0.001 $ 0.001        
Share price             $ 10.00          
Purchase price             $ 9,500          
Proceeds from Warrant Exercises           $ 4        
Stock-based compensation           $ 965 1,013 $ 947        
Common Stock [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Issuance of common stock, net, shares               58,000        
Common Stock [Member] | M D M Worldwide Solutions Inc [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares agreed to issue                 2,500      
Stock-based compensation             25,000          
Common Stock [Member] | Common Stock To Maxim Group Llc [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares agreed to issue                     16,854  
Stock-based compensation             300          
Common Stock [Member] | Services Agreement With Maxim Mdm Worldwide Solutions [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares agreed to issue                       2,500
Stock-based compensation             $ 79,000          
JT Pharmaceuticals [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Issuance of common stock, net, shares         2,552              
Milestone payment         $ 100,000              
Pre-Funded Warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of warrants issued 64,490 65,000 48,712                  
Proceeds from Warrant Exercises $ 1,290 $ 1,300 $ 1,000                  
February 2022 Offerings [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Issuance of common stock, net, shares       55,000                
Proceeds from sale of common stock       $ 5,000                
February 2022 Offerings [Member] | Pre-Funded Warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of warrants issued       113,712                
Exercise price of warrants, shares       $ 0.02                
February 2022 Offerings [Member] | Unregistered prefunded warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of warrants issued       64,490                
Exercise price of warrants, shares       $ 0.02                
February 2022 Offerings [Member] | Unregistered five year and six month warrants [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of warrants issued       233,202                
Exercise price of warrants, shares       $ 22.80                
N 2015 Omnibus Equity Incentive Plan [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of shares agreed to issue                   125,000